Further analyses indicated that the association was specific to non-scarring alopecia (where hair follicles remain intact, leaving the potential for regrowth) with an increased risk of 53% and 72% compared with SGLT-2 inhibitors and DPP-4 inhibitors, respectively
If your state Medicaid denies coverage, you can appeal with additional documentation, request a formulary exception, or explore cash-pay pricing ($349 monthly) or compounded semaglutide ($199 monthly) as alternatives
However, these are not grounded in definitive evidence
Excess sugar is supposed to be relegated to the liver until the body needs it
A Prime Therapeutics analysis (2024) found GLP-1 use raised annual healthcare costs by 46% for obese patients in two years versus controls ( [71] ), mainly driven by drug spending
Semaglutide, a modified peptide manufactured by Novo-Nordisk and marketed as Wegovy, is currently the only FDA-approved medication for weight loss in this category